Effect of persistent versus transient donor-specific HLA antibodies on graft outcomes in pediatric cardiac transplantation

De novo HLA antibodies are detectable post-transplant in the majority of patients, but non-DSA and transient DSA do not appear to be associated with poor outcomes. Patients with persistent DSA, especially those with Class II DQ antibodies, have worse survival.